Eastgate Biotech Corp
OTC:ETBI
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
|
Eastgate Biotech Corp
OTC:ETBI
|
1.6m USD |
Loading...
|
|
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD |
Loading...
|
|
| SE |
Z
|
Zinzino AB
STO:ZZ B
|
3.9B SEK |
Loading...
|
|
| CN |
S
|
Shanghai Aiyingshi Co Ltd
SSE:603214
|
2.6B CNY |
Loading...
|
|
| CN |
N
|
Nanjing Sinolife United Co Ltd
HKEX:3332
|
680.9m HKD |
Loading...
|
|
| CA |
|
Nova Cannabis Inc
TSX:NOVC
|
108.6m CAD |
Loading...
|
|
| US |
|
Franchise Group Inc
F:3HC
|
38.8m EUR |
Loading...
|
|
| JP |
|
Soiken Holdings Inc
TSE:2385
|
6.7B JPY |
Loading...
|
|
| HK |
|
Ausupreme International Holdings Ltd
HKEX:2031
|
247.7m HKD |
Loading...
|
|
| NZ |
|
Comvita Ltd
NZX:CVT
|
48.6m NZD |
Loading...
|
|
| AU |
|
Star Combo Pharma Ltd
ASX:S66
|
31.7m AUD |
Loading...
|
Market Distribution
| Min | -4 418 600% |
| 30th Percentile | -9.6% |
| Median | 3.1% |
| 70th Percentile | 11.3% |
| Max | 1 135 400% |
Other Profitability Ratios
Eastgate Biotech Corp
Glance View
Eastgate Biotech Corp. engages in the development of novel formulations of natural compounds and pharmaceutical products. The company is headquartered in Salt Lake City, Utah. The company went IPO on 2014-01-16. The firm produces and distributes nutraceuticals that are based on natural therapies and absorbed naturally by the body. The company utilizes state-of-the-art nanotechnologies to deliver healthy alternatives to conventional pharmaceuticals that all-too-often create dangerous side-effects and unexpected consequences for those trying to attain and maintain healthy lives. The Company’s products include E-Drops NANO, Essential D, GluCora, VCleanzz, Cleanezze and Warts X. The firm develops products in which the components are incorporated into vehicles containing nano-sized delivery vectors, including oil droplets (nanoemulsions), polymeric particles (nanoparticles) and the combination of polymers and lipids with surfactants (hybrid nanoparticles, nanocapsules, mixed micelles).
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
Over the last 2 years, Eastgate Biotech Corp’s Net Margin has increased from -7 716.7% to -5 217.2%. During this period, it reached a low of -7 716.7% on Jun 30, 2015 and a high of -3 046.2% on Mar 31, 2016.
